logo
logo

Sonic Incytes Medical Corp. Successfully Completes Series A Raise Of Us$7.3M To Accelerate Velacur™ Commercialization

Dec 07, 2021over 3 years ago

Round Type

series a

Vancouver

Description

Sonic Incytes Medical Corp., a health technology company focused on liver health, is pleased to announce the completion of its US$7.3M Series A with backing from Nimbus Synergies as the lead investor, and support from Nicola Wealth, Mint Venture Partners, Consortium Medteq, Wavemaker Three-Sixty Health, Gaingels and INP Capital, as well as notable angel investors.

Company Information

Company

Sonic Incytes

Location

Vancouver, Washington, United States

About

Founded in 2017, Sonic Incytes is a health technology company headquartered in Vancouver, British Columbia, Canada.

FundzWatch™ Score

62
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood